Ceftobiprole medocaril

Zevtera 500 MG Polvo Para Concentrado Para Solucion Para Perfusion

666.6 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 25 Apr 2014

In other countries

The same active substances on other registers, the same brand first.

ZevteraBrazil · United Medical LtdaSame brand
ZevteraCanada · 500 MG / VIAL · Powder For Solution · Avir Pharma INC.Same brand
ZEVTERA 500 mg Powder for concentration for Solution for InfusionSaudi Arabia · Nipro Pharma Corporation Ise PlantSame brand
ZevteraUnited States · 667MG/VIAL · powder · IstxSame brand
MabelioItaly · Polvere per concentrato per soluzione per infusione · Advanz Pharma LimitedSame form
ZefteraCanada · 500 MG / VIAL · Powder For Solution · Janssen INCSame substance
Zeftera (previously Zevtera)European Union · Janssen-Cilag International NVSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ceftobiprole medocaril

Zevtera 500 MG Polvo Para Concentrado Para Solucion Para Perfusion

666.6 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 25 Apr 2014

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
ZEVTERA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales de 20 ml	702137

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ceftobiprole medocaril
Strength: 666.6 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 25 Apr 2014
Registration: 78691
Marketing authorisation holder: Advanz Pharma Limited
Procedure: National, MRP or DCP
Supply: Uso Hospitalario